Table 2 Clinical assessment of studied patients
| Â | Number | Percent (%) | |
|---|---|---|---|
Group (COPD severity) | A | 13 | 13.0 |
B | 16 | 16.0 | |
C | 8 | 8.0 | |
D | 63 | 63.0 | |
GOLD (severity of airway limitation) | 1 | 12 | 12.0 |
2 | 41 | 41.0 | |
3 | 25 | 25.0 | |
4 | 20 | 20.0 | |
Exacerbation grade | Mild | 37 | 37.0 |
Moderate | 53 | 53.0 | |
Severe | 10 | 10.0 | |
Comorbid diseases | Present | 67 | 67.0 |
Absent | 33 | 33.0 | |
Treatment | |||
 Systemic steroids | Not used | 98 | 98.0 |
Used | 2 | 2.0 | |
 Oxygen therapy | Not used | 85 | 85.0 |
Used | 15 | 15.0 | |
 Non-invasive ventilation | Not used | 97 | 97.0 |
Used | 3 | 3.0 | |